Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 4, 2025 • 8:00 AM ET

Date/Time Source News Release
11/13/2024 07:00 AM EST GlobeNewswire Tenax Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
10/31/2024 04:05 PM EDT GlobeNewswire Tenax Therapeutics to Present at the Guggenheim Healthcare Innovation Conference
08/13/2024 04:05 PM EDT GlobeNewswire Tenax Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
08/12/2024 08:00 AM EDT GlobeNewswire Tenax Therapeutics Announces Closing of $100 Million Private Placement and Plans to Accelerate the Oral Levosimendan Phase 3 Program
08/06/2024 07:13 AM EDT GlobeNewswire Tenax Therapeutics Announces Oversubscribed $100 Million Private Placement
05/14/2024 08:00 AM EDT GlobeNewswire Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
04/30/2024 07:30 AM EDT GlobeNewswire Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
04/09/2024 08:30 AM EDT GlobeNewswire Tenax Therapeutics to Host KOL Event: "LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study"
03/28/2024 08:30 AM EDT GlobeNewswire Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results
03/12/2024 08:30 AM EDT GlobeNewswire Tenax Therapeutics to Present at the 36th Annual Roth Conference
Page

Additional News

As of January 4, 2025 • 8:00 AM ET

Date/Time Source News Release
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Tenax Therapeutics Inc.
11/15/2024 11:47 AM EST SeekingAlpha Tenax Therapeutics, Inc. (TENX) Guggenheim Healthcare Innovation Conference (Transcript)
11/13/2024 07:28 AM EST SeekingAlpha Tenax Therapeutics GAAP EPS of -$0.19
10/20/2024 06:02 AM EDT SeekingAlpha Tectonic Therapeutic: Interesting CV Disease Drug Developer
10/14/2024 08:15 AM EDT KlickAnalytics Buy Recommendation Issued On TENX By Guggenheim
08/13/2024 05:53 PM EDT SeekingAlpha Tenax Therapeutics GAAP EPS of -$1.83 beats by $0.42
08/06/2024 04:22 PM EDT y%wire Biotech Stock Soars Following Oversubscribed $100M Private Placement Announcement
08/06/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Tue, Aug 06, 2024 as of 10.00 am ET
05/14/2024 10:42 AM EDT SeekingAlpha Tenax Therapeutics GAAP EPS of -$3.12
03/28/2024 08:44 AM EDT SeekingAlpha Tenax Therapeutics GAAP EPS of -$31.04
Page